Objective: Pancreatic transplantation has been relatively uncommon until the last 2 decades, but is now an accepted therapeutic intervention for type I diabetes. Core biopsies of pancreas transplants are frequently performed to rule out rejection, which is a leading cause of graft failure. Often, it is difficult to localize the graft for biopsy by imaging. Our objective was to determine whether on-site assessment by cytopathology can assist in procedure protocols for biopsy of pancreas transplants. Study Design: We reviewed cytology and surgical pathology reports from 68 instances of pancreas transplant biopsy at our institution and evaluated the correlation between cytology (fine needle aspiration, touch preparation or both) and the final core biopsy. Results: Pancreatic tissue was identified by on-site assessment in 56/68 cases and was present on core biopsy in 53/68 cases. There were 3 cases where fine needle aspiration/touch preparation results were not concordant with final core biopsy results. The positive predictive value of a positive on-site assessment was 96.4%. More importantly, the negative predictive value of on-site assessment was 100%. Conclusions: On-site evaluation by cytopathology is highly effective for the identification of transplant pancreas. In cases where no pancreatic tissue is identified by on-site assessment, relocalization of the biopsy needle is recommended.

Journal Section:
Editor's choice
Keywords:
Pancreas transplant, Fine needle aspiration, Cytopathology, Rejection, On-site evaluation
1.
Sutherland DE, Gruessner RW, Dunn DL, Matas AJ, Humar A, Kandaswamy R, Mauer SM, Kennedy WR, Goetz FC, Robertson RP, Gruessner AC, Najarian JS: Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001;233:463-501.
[PubMed]
https://doi.org/10.1097/00000658-200104000-00003
2.
Gruessner AC, Sutherland DE: Pancreas transplant outcomes for United States cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Clin Transpl 2008:45-56.
[PubMed]
3.
Vandermeer FQ, Manning MA, Frazier AA, Wong-You-Cheong JJ: Imaging of whole- organ pancreas transplants. Radiographics 2012;32:411-435.
[PubMed]
https://doi.org/10.1148/rg.322115144
4.
Lee BC, McGahan JP, Perez RV, Boone JM: The role of percutaneous biopsy in detection of pancreatic transplant rejection. Clin Transplant 2000;14:493-498.
[PubMed]
https://doi.org/10.1034/j.1399-0012.2000.140508.x
5.
Malek SK, Potdar S, Martin JA, Tublin M, Shapiro R, Fung JJ: Percutaneous ultrasound-guided pancreas allograft biopsy: a single-center experience. Transplant Proc 2005;37:4436-4437.
[PubMed]
https://doi.org/10.1016/j.transproceed.2005.10.023
6.
Nikolaidis P, Amin RS, Hwang CM, et al: Role of sonography in pancreatic transplantation. Radiographics 2003;23:939-949.
[PubMed]
https://doi.org/10.1148/rg.234025160
7.
Daly B, O'Kelly K, Klassen D: Interventional procedures in whole organ and islet cell pancreas transplantation. Semin Intervent Radiol 2004;21:335-343.
[PubMed]
https://doi.org/10.1055/s-2004-861568
8.
Klassen DK, Weir MR, Cangro CB, Bartlett ST, Papadimitriou JC, Drachenberg CB: Pancreas allograft biopsy: safety of percutaneous biopsy - results of a large experience. Transplantation 2002;73:553-555.
[PubMed]
https://doi.org/10.1097/00007890-200202270-00011
9.
Drachenberg CB, Odorico J, Demetris AJ, Arend L, Bajema IM, Bruijn JA, Cantarovich D, Cathro HP, Chapman J, Dimosthenous K, Fyfe-Kirschner B, Gaber L, Gaber O, Goldberg J, Honsová E, Iskandar SS, Klassen DK, Nankivell B, Papadimitriou JC, Racusen LC, Randhawa P, Reinholt FP, Renaudin K, Revelo PP, Ruiz P, Torrealba JR, Vazquez-Martul E, Voska L, Stratta R, Bartlett ST, Sutherland DE: Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel. Am J Transplant 2008;8:1237-1249.
[PubMed]
https://doi.org/10.1111/j.1600-6143.2008.02212.x
10.
Sariya D, Kluskens L, Assad L, Treaba D, Reddy V, Gattuso P: Diagnostic role of fine-needle aspiration of pancreatic allograft to detect rejection. Diagn Cytopathol 2002;27:266-270.
[PubMed]
https://doi.org/10.1002/dc.10179
© 2013 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2013
You do not currently have access to this content.